Green Elephant Biotech announces the market introduction of Archimedes® One, the first system in a new category called the ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...
With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity ...
Metabolism is more than burning calories. UAB experts explain how metabolism develops from before birth through older ...
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech's New York Reference Laboratory DUBLIN and NEW YORK, ...
Josh Lauer explores the trends shaping sequencing, the science behind SBX technology, and how AXELIOS 1 is designed to ...
He reassured the patient that a standard course of antibiotics would do the trick. But Gerry Wright was not a run-of-the-mill ...
Researchers found that GLP-1 medicines caused weight loss mainly through fat reduction, with only modest decreases in ...
As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results